Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study

NCT07662655 is registered in ClinicalTrials.gov with Xiamen Cardiovascular Hospital, Xiamen University as lead sponsor.

NCT NCT07662655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07662655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study
Lead sponsor
Xiamen Cardiovascular Hospital, Xiamen University
Phase
Phase 1
Overall status
Recruiting
Start date
June 6, 2026
Completion date
August 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, pulmonary hypertension associated with hfpef